What are the initial laboratory tests for diagnosing Cushing's syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Laboratory Tests for Diagnosing Cushing's Syndrome

The initial laboratory tests for diagnosing Cushing's syndrome should include 24-hour urinary free cortisol (UFC), late night salivary cortisol (LNSC), and overnight 1-mg dexamethasone suppression test (DST), with at least two different tests recommended for patients with intermediate to high clinical suspicion. 1, 2

Diagnostic Algorithm

Step 1: Assess Clinical Suspicion and Rule Out Exogenous Glucocorticoids

  • First determine if the patient is taking exogenous glucocorticoids (oral, injections, inhalers, topical)
  • If yes, stop glucocorticoids if possible and reassess
  • Evaluate clinical likelihood of endogenous Cushing's syndrome (CS)

Step 2: Select Initial Screening Tests Based on Clinical Suspicion

For Low Clinical Suspicion:

  • Single screening test (any of the following):
    • Late night salivary cortisol (LNSC)
    • 24-hour urinary free cortisol (UFC)
    • Overnight 1-mg dexamethasone suppression test (DST)

For Intermediate or High Clinical Suspicion:

  • 2-3 screening tests from the options above

Step 3: Interpret Results and Follow-Up

  • If normal: CS is unlikely
  • If abnormal: Repeat 1-2 screening tests
  • If still abnormal: Exclude non-neoplastic hypercortisolism
  • If equivocal: Consider additional tests (Dex-CRH, DDAVP, midnight serum cortisol)

Key Considerations for Each Test

24-Hour Urinary Free Cortisol (UFC)

  • Reflects overall cortisol production
  • Collect 2-3 specimens for confirmation
  • Avoid in patients with creatinine clearance <60 mL/min 2
  • False positives can occur with high fluid intake, certain medications

Late Night Salivary Cortisol (LNSC)

  • High sensitivity (>90%) and specificity (100%) 2
  • Easier for patient collection (≥2 on consecutive days recommended)
  • Particularly useful for detecting loss of normal circadian rhythm
  • Excellent for longitudinal surveillance of cyclic CS

Overnight 1-mg Dexamethasone Suppression Test (DST)

  • Useful in patients with disrupted circadian rhythms (e.g., shift workers)
  • Not recommended in women taking estrogen-containing oral contraceptives
  • Consider measuring dexamethasone levels along with cortisol to improve test interpretability 1, 2
  • A cortisol cutoff of <1.8 μg/dL may increase sensitivity 3

Important Caveats and Pitfalls

False Positives

  • Several conditions can cause false positive results:
    • Severe obesity
    • Pregnancy
    • Polycystic ovary syndrome (PCOS)
    • Uncontrolled diabetes mellitus
    • Anorexia/malnutrition
    • Acute illness/surgery
    • Excessive exercise
    • Depression and alcoholism (pseudo-Cushing's states) 2

Medication Interference

  • Certain medications can alter cortisol metabolism or interfere with measurements:
    • Anticonvulsants
    • Oral estrogens
    • CYP3A4 inducers/inhibitors
    • Grapefruit juice
    • Licorice 2

Dexamethasone Bioavailability

  • Inadequate dexamethasone levels can cause false positive DST results
  • Consider measuring serum dexamethasone during DST
  • Dexamethasone levels <1.8 ng/mL suggest inadequate absorption or compliance 3
  • Renal dysfunction and diabetes can affect dexamethasone levels 3

Mild or Cyclic Cushing's Syndrome

  • Standard tests may miss mild or episodic hypercortisolism
  • The overnight DST has reduced sensitivity (as low as 18-41%) in mild/periodic CS 4
  • Multiple tests over time may be necessary for diagnosis

Next Steps After Initial Testing

If initial tests suggest Cushing's syndrome, proceed to:

  1. Measure plasma ACTH to differentiate ACTH-dependent from ACTH-independent CS
  2. Further imaging and specialized testing based on ACTH results

Remember that early diagnosis is critical given the significant morbidity and mortality associated with prolonged hypercortisolism 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cortisol Measurement and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.